Private Equity
Apax Partners’ planned offer for London-listed Pinewood.AI, an automotive tech firm, has been called off.
4 min read · 16 February 2026
The Tokyo Stock Exchange is increasing minimum market capitalisation for companies listed in its Growth Market section to ¥10bn by 2030.
6 min read · 16 February 2026
The growing prevalence of heart-related issues is driving demand in cardiological care, and in turn, getting interest from private equity firms such as Antin, Arcline and Carlyle; growing regulatory support and biotech company growth are drawing private equity to regenerative medicine; healthcare investors saw wins in the fourth quarter.
5 min read · 13 February 2026
England’s North West, once a by-word for decline, is open for business. Filling significant gaps in the funding ecosystem offers great opportunities for innovative investment – and positive social outcomes, write Palatine's Gary Tipper and Beth Houghton.
4 min read · 13 February 2026
Antin, Arlington, Carlyle, GTCR and Webster Equity are among the PE firms pursuing investments in the heart health market.
4 min read · 13 February 2026
Schroders will continue to operate as a standalone business within the wider Nuveen group.
4 min read · 13 February 2026
Schroders Capital, the private capital arm of Schroders, manages more than $25bn in private equity assets.
3 min read · 12 February 2026
Q4 marked the weakest finish in five years for PE deal volume. We take a close look; weekly companies-for-sale update, highlighting exits from Blackstone Energy Partners and Audax Private Equity.
5 min read · 12 February 2026
The merged entity will boast a combined real estate heft of around $172bn in assets under management across equity and debt in all major regions.
3 min read · 12 February 2026
Not only are fourth quarters usually stronger, they are usually the strongest quarter of their years. This was not the case in 2025.
4 min read · 12 February 2026